These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20139094)

  • 1. Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease.
    Burnier L; Saller F; Kadi L; Brisset AC; Sugamele R; Baudino L; Bono F; Herbert JM; Carmeliet P; Schapira M; Izui S; Angelillo-Scherrer A
    Blood; 2010 Apr; 115(16):3390-7. PubMed ID: 20139094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.
    Wu Y; Fu J; Wang H; Yu XZ
    Front Immunol; 2021; 12():778996. PubMed ID: 34950143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice.
    Fu J; Wu Y; Nguyen H; Heinrichs J; Schutt S; Liu Y; Liu C; Jin J; Anasetti C; Yu XZ
    J Immunol; 2016 Apr; 196(7):3168-79. PubMed ID: 26903480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.
    Liang Y; Liu C; Djeu JY; Zhong B; Peters T; Scharffetter-Kochanek K; Anasetti C; Yu XZ
    Blood; 2008 Jan; 111(2):954-62. PubMed ID: 17928532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.
    Iliopoulou BP; Hsu K; Pérez-Cruz M; Tang SW; Pang WW; Erkers T; Kambham N; Freeman GJ; Dekruyff RH; Meyer EH
    Blood Adv; 2019 Nov; 3(21):3419-3431. PubMed ID: 31714958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease.
    Kawasaki Y; Sato K; Hayakawa H; Takayama N; Nakano H; Ito R; Mashima K; Oh I; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Fujiwara SI; Ohmine K; Muroi K; Kanda Y
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1563-1574. PubMed ID: 29678638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
    van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
    J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD.
    Furukawa M; Wang X; Ohkawara H; Fukatsu M; Alkebsi L; Takahashi H; Harada-Shirado K; Shichishima-Nakamura A; Kimura S; Ogawa K; Ikezoe T
    Blood Adv; 2019 Jul; 3(14):2128-2143. PubMed ID: 31300420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
    MacDonald KP; Rowe V; Filippich C; Thomas R; Clouston AD; Welply JK; Hart DN; Ferrara JL; Hill GR
    Blood; 2003 Mar; 101(5):2033-42. PubMed ID: 12393418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent kinase 5 activity is required for allogeneic T-cell responses after hematopoietic cell transplantation in mice.
    Askew D; Pareek TK; Eid S; Ganguly S; Tyler M; Huang AY; Letterio JJ; Cooke KR
    Blood; 2017 Jan; 129(2):246-256. PubMed ID: 28064242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
    Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG
    J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells.
    Waller EK; Boyer M
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S20-4. PubMed ID: 10933181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth arrest-specific 6 regulates thrombin-induced expression of vascular cell adhesion molecule-1 through forkhead box O1 in endothelial cells.
    Bertin FR; Lemarié CA; Robins RS; Blostein MD
    J Thromb Haemost; 2015 Dec; 13(12):2260-72. PubMed ID: 26414399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute graft-vs-host disease: pathobiology and management.
    Goker H; Haznedaroglu IC; Chao NJ
    Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
    Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver.
    Schreder A; Moschovakis GL; Halle S; Schlue J; Lee CW; Schippers A; David S; Bernhardt G; Ganser A; Pabst O; Förster R; Koenecke C
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2069-2078. PubMed ID: 26348893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients.
    Marks L; Altman NH; Podack ER; Levy RB
    Transplantation; 2004 Mar; 77(6):804-12. PubMed ID: 15077018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells.
    Satake A; Inoue T; Kubo S; Taniguchi Y; Imado T; Fujioka T; Horiuchi M; Xu Y; Ikegame K; Yoshihara S; Kaida K; Tamaki H; Okada M; Okamura H; Ogawa H
    Int J Hematol; 2010 Apr; 91(3):485-97. PubMed ID: 20300982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects.
    Giver CR; Montes RO; Mittelstaedt S; Li JM; Jaye DL; Lonial S; Boyer MW; Waller EK
    Biol Blood Marrow Transplant; 2003 Oct; 9(10):616-32. PubMed ID: 14569558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.